ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.9581C>A (p.Pro3194Gln) (rs28897760)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000131306 SCV000186278 likely benign Hereditary cancer-predisposing syndrome 2017-12-14 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Other data supporting benign classification,Co-occurence with a mutation in another gene that clearly explains a proband's phenotype
Breast Cancer Information Core (BIC) (BRCA2) RCV000031833 SCV000147668 uncertain significance Breast-ovarian cancer, familial 2 2004-02-20 no assertion criteria provided clinical testing
Color RCV000131306 SCV000689208 likely benign Hereditary cancer-predisposing syndrome 2017-06-12 criteria provided, single submitter clinical testing
Counsyl RCV000031833 SCV000487802 uncertain significance Breast-ovarian cancer, familial 2 2015-11-18 criteria provided, single submitter clinical testing
GeneDx RCV000160173 SCV000210511 likely benign not specified 2017-05-08 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Integrated Genetics/Laboratory Corporation of America RCV000160173 SCV000917016 likely benign not specified 2018-08-05 criteria provided, single submitter clinical testing Variant summary: BRCA2 c.9581C>A (p.Pro3194Gln) results in a non-conservative amino acid change located in the no known domain of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.4e-05 in 277716 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.9581C>A has been reported in the literature in individuals affected with Hereditary Breast and Ovarian Cancer(Palmero_2015, Yilmaz_2016, Brianese_2018). These report(s) do not provide unequivocal conclusions about association of the variant with Hereditary Breast and Ovarian Cancer. This variant has been reported in one individual who was older than age 70 and cancer free. Co-occurrences with other pathogenic variant(s) have been reported (BRCA2 c.3978_3979ins4, p.Ala1327fsX4; BRCA1 c.5266dupC, p.Gln1756Profs*74), providing supporting evidence for a benign role. One publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect (Tram_2013). Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments. Based on the evidence outlined above, the variant was classified as likely benign.
Invitae RCV000045860 SCV000073873 likely benign Hereditary breast and ovarian cancer syndrome 2018-01-13 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000160173 SCV000600868 uncertain significance not specified 2017-03-24 criteria provided, single submitter clinical testing
Sharing Clinical Reports Project (SCRP) RCV000031833 SCV000054441 benign Breast-ovarian cancer, familial 2 2012-02-08 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.